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Most antigen-specific peripheral murine Tlymphocytes express the Tcell differen-
tiation antigens, CD4 or CD8, and a TCRcomposed ofaCD3-associated disulfide-
linked heterodimer, TCR-a/(3 (1, 2). However, recent studies have identified a dis-
tinct population of CD3+,CD4-,CD8- cells that appear early in thymic ontogeny
and are maintained in the mature thymus and the peripheral lymphoid organs
throughout adult life (3-5). Immunoprecipitation studies of murine CD3+,CD4-,
CD8- T cells have shown that the majority ofthese cells do not express cell surface
TCRa/a; rather their TCR complex includes a 45-kD S glycoprotein disulfide linked
to either the TCRVy/Cylt gene product or the TCRVy/Cy4 gene product (demon-
strated by immunoprecipitation with antiTCRy antisera) (5-7). These results sug-
gested that the TCR-,y/8' cells may compose a separate lineage that develops in the
thymus before the TCRa/R-expressing T cells (7).
If the TCR-y/8' T cells are a distinct lineage, then what is their function and
specificity? One characteristic ofTCRa/a-bearing cells that distinguishesthem from
B lymphocytes is the skewing of their repertoire toward the recognition of MHC
molecules (8, 9). MHC-restricted antigen recognition has been definitively attrib-
uted to theTCRa/a heterodimer by experiments in which transfection and expres-
sion ofTCR a and R chains of a given T cell clone confer both the clone's antigen
specificity and MHC restriction specificityon the transfected cell (11, 12). Although
the TCR-a/a heterodimers are distinct from the TCRy/S heterodimers, these two
types ofTCR have structural characteristics in common. Like the TCRa/R receptor
(1, 2), the TCRy/S receptors are heterodimers noncovalently associated with CD3
(3, 7, 13-16). In addition, both the TCRy and S gene products are formed by in-
frame rearrangements ofdistinct V, (D), andj gene segments during Tcell develop-
ment (17, 18). Interestingly, the gene elements encoding the TCR-S gene are local-
ized within the TCRa gene complex, and rearrangements of Va segments to DS
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andJS have been described (19, 20) . These structural similarities, as well as the pres-
ence of TCR-y/8-bearing T cells in the thymus, raise the possibility that TCRy/S
cells may also recognize MHC antigens . To address this question, we have gener-
ated alloreactive CD3 +,CD4-,CD8- TCRy/S cell lines and clones. One such TCR
y/S cytolyticT cell (CTL) line was shown to recognize an MHC-linked antigen (21) .
Thepresent studies were undertaken to examine thenature ofthe MHC-linked ligand
of the TCRy/S CTL line and clones and to analyze the biochemical and molecular
nature of the TCR proteins expressed on the cell surface . We have also developed
additional MHC-specific TCRy/S CTL in order to begin to explore the diversity
of receptor expression and the MHC molecule recognition by this T cell subset .
Materials and Methods
Animals .
￿
BALB/c and C57BL/10 (1110) nu/nu mice, 2-10 mo old, were purchased from
the Frederick Animal Research Facility (Frederick, MD) . All other inbred and congeneic
mice were purchased from TheJackson Laboratory (Bar Harbor, ME) or were bred in our
own colony (National Institutes of Health, Bethesda, MD).
MonoclonalAntibodies andAntisera.
￿
ThemAb 145-2C11, specific for theCD3-schain of the
TCR complex, wasderived in our laboratory (22) . The anti-Cyl/Cy2 and anti-C,4 antisera
were generated by injecting rabbitswith synthetic peptides derived from published gene se-
quences as previously described (3,5) .
T Cell Lines and Clones.
￿
The derivation and propagation of the MHC-specific CD3',
CD4-,CD8- T cell lines has been described (21) . Clones were derived from the lines by lim-
iting dilution . Briefly, 2 d after stimulation, activated T cells were added to individual wells
of 96-wellflat-bottomed microtiter plates at 0.5 cells/well in the presence of 100 U/ml human
rIL-2 (Lot LP315; CetusCorp., Emeryville, CA ; reference 23) and 5 x 10 5 irradiated (3,000
rad) allogeneic spleen cells . After 1-2 wk, cells from positive wells were transferred to 24-well
plates with additional IL-2 and irradiated allogeneic stimulator cells. Thereafter thecloned
cells were propagated in the same fashion as the T cell lines . CD3',CD4-,CD8- bulk TCR-
y/S T cells were derived as described elsewhere (5) . Erythrocyte-depleted, freshly isolated
BALB/c splenocytes were suspended in complete medium (RPMI 1640 supplemented with
glutamine, 10% FCS, 2-ME (5 x 10-5 M), Hepes buffer, and nutrient mix [sodium pyru-
vate, nonessential amino acids, glutamine, penicillin, streptomycin ; NIH media unit]) at 107
cells/ml. Cells were incubated with anti-Lyt-2 .2 (83-12-5, reference 24) and anti-L3T4 (RL
172.4, reference 25)mAb culture supernatants, each at a final concentration of 25%, for 30
min at room temperature . Cells were washed in complete medium and resuspended at 10 7
cells/ml in completemedium containing apreselected concentration of rabbit sera (asasource
of complement). The cells were incubated for30 min at 37°C andwere washed again . Dead
cells were removed by centrifugation on a Ficoll-Hypaque gradient (LymphocyteM; Cedarlane
Laboratories Ltd., Ontario, Canada) . Viable cells were cultured for 2 d in the presence of
anti-CD3 mAb followed by 3 d in IL-2-containing Con A-induced culture supernatants .
Lymphokine Assays.
￿
The secretion of soluble lymphokines was monitored by the ability
of culture supernatants of activated T cells (collected after 24 h of incubation) to support
thegrowth ofthelymphokine-dependent HT-2 cell line (kindlyprovided byDr. RichardHodes,
NIH) . 5 x 103 HT-2 cells were cultured for 24-36 h with the supernatants to be assayed,
then pulsed for 16h with 1 gCi of [3H]thymidine. IFN-y was assayed as previously described
using an ELISA method (26) .
Biochemical Analysis .
￿
Cultured alloreactive T cells were 1251 surface labeled by the lac-
toperoxidase method (3) and lysed in 1% digitonin buffer for anti-CD3 and anti-Cy4 im-
munoprecipitations, or in 0.5% NP-40 lysis buffer for anti-Cyl/Cy2 precipitations as de-
scribed (5) . Lysates were precleared overnight at4°Cwith proteinA agarosebeadsandrabbit
anti-eosin (coupled toKLH) antiserum(a kind gift fromDr . Pierre Henkart, NIH) . Precleared
lysates were immunoprecipitated with 50 ul of anti-CD3 culture supernatant or 20 wl of rabbit
antiTCR antisera and were analyzed by SDS-PAGE as described (3) . Proteins were visual-BLUESTONE ET AL .
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ized by drying the gels and developing withKodakXAR5 film in cassettes containing Light-
ning Plus developing screens (DuPont Co., Wilmington, DE), stored at -70°C . Approxi-
mate molecular weights of proteins were determined by comparison to Bethesda Research
Laboratories (Gaithersburg, MD) or Amersham Corp. (Arlington Heights, IL) prestained
high molecular weight standard markers that were electrophoresed in the same gels . N-gly-
cosidase treatment and reduction/alkylation procedures were performed as previously de-
scribed (5) .
Northern and Southern Blot Analyses.
￿
Cellular RNA was prepared after extraction with
guanidinium isothiocyanate (27) . 10 gg/lane ofRNA was subjected to electrophoresis on 1%
agarose/0.7% formaldehyde gels at 100 V for 4 h before transfer to nitrocellulose filters . 10
Rg of high molecular weight DNA was digested to completion with the indicated restriction
enzymes according to the manufacturer's specifications and was subjected to electrophoresis
on 0.8% agarose gels at 25 V for 36 h . Southern transfers, hybridization, and washes were
performed as previously described (28, 29) . Sizes of labeled DNA fragments were calculated
from a Hind III digest of phage X DNA.
cDNA Cloning and Sequencing .
￿
Poly(A)' RNA was isolated by oligo(dT)-cellulose (type 7 ;
Pharmacia Fine Chemicals, Piscataway, NJ) chromatography (30) . First and second strand
cDNA synthesis, and cloning into phage Xgt10 were performed using kits supplied by Amer-
sham Corp . according to the manufacturer's specifications . cDNA was size selected by chro-
matography over Sephanyl S-500, superfine (Pharmacia Fine Chemicals) . ThecDNA library
was screened by phage filter hybridization using theCS probe . DNA purified from individual
positive recombinant plaques were digested with Eco RI and Klenow labeled with 7 - [ 32P]-
dATP(New England Nuclear, Boston, MA) . DNA fragments were subcloned into M13Mp9
(31) and sequenced by the dideoxynucleotide chain termination method (32) .
DNA Probes .
￿
The Vrl, VY2, VY3, and VY4 probes, all cloned into the pGEM II vector,
were the generous gift of Dr. David Raulet (MIT, Boston, MA) (10) . Vyl is a 500-bp Eco
RI-Hind III fragment ; Vy2 is an 800-bp Eco RI-Pst I fragment; VY3 is a 300-bp Eco RI
fragment ; and Vy4 is a 1 .2-kb Hind III-Sph I fragment . The Ca probe, generously provided
by Drs . Tom McMillen and John Coligan (National Institute ofAllergy and Infectious Dis-
eases, NIH, Bethesda, MD) is a 500-bp Eco RI fragment derived from a full-length cDNA
clone . TheJal probe is a 3' genomic Eco RI-Hind III fragment cloned into pGEM3 . The
,J62 probe is a 2.5-kb Eco RI-Xba I fragment cloned into the same vector. Both probes were
kindly provided by Dr. Yueh-hsiu Chien, Stanford University, Stanford, CA (19) .
Cell-mediated Cytolysis Assay.
￿
1-5 x 10 6 target cells (Con A-induced splenic blasts) were
radiolabeled with 5'NaCrO3 (300 pCi, Amersham Corp.) for 1 h at 37 °C . Effector cells were
harvested 1-2 d after removal of exogenous rIL-2 after stimulation, washed, resuspended
in culture medium, and plated in 96-well U-bottomed microculture plates (Costar, Cam-
bridge, MA) containing 1-2 x 103 radiolabeled target cells at selected E/T ratios. After a
4-h incubation at 37°C, the culture supernatants were harvested using the Titertek superna-
tant collection system (Skatron Inc., Sterling, VA) . The percentage ofspecific lysis was calcu-
lated using the formula: Percent specific lysis = 100 x [(Experimental cpm - spontaneous
cpm)/(maximum cpm - spontaneous cpm)] . Experimental cpm represents the"Cr released
from target cells incubated with effector cells . Maximum cpm represents the release of radio-
label from target cells in a 0.05 N solution ofHCL . Spontaneous cpm represents the back-
ground release of target cells cultured in media in the absence of effector cells .
Results
TCR-y/8 CTL Can Recognize a Relatively Nonpolymorphic MHC-linked Class I Mole-
cule. To identify potential ligands for T cells expressingTCRY/S receptors, we de-
rived an alloreactive T cell line from the peripheral lymph nodes of BALB/c (H-2d)
nu/nu mice stimulated with low density B10.BR (H-2k) spleen cells (21) . Phenotypic
and biochemical analyses demonstrated that this cell line was CD3+,CD4-,CD8-
and expressed the product of a rearrangedTCRCr l gene on its surface (21) . Func-1902
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tional analysis ofthe BALB/c nu/nu-derived T cell line showed that it recognized
H-2'-expressingbut not H-2d-expressing target cells, asjudged by proliferation and
cytolysis (21). When assayed forlymphokine production(Fig. 1), both H-2-congenic
B10.BR andBALB.Kstimulator spleen cells(APC)inducedthe productionofIFN-
y and a lymphokine capable ofsupporting the proliferation of HT-2 cells. Interest-
ingly, further analysis has shown that these y/S cells produce granulocyte/macro-
phage colony-stimulating factor but no detectable IL-2 or IL-4 (Cron, R. Q, T F.
Gajewski, S. O. Sharrow, F. W. Fitch, L. Matis, J. A. Bluestone, submitted forpub-
lication). In contrast, H-2-identical BALB/c and B10.D2 APC did not induce lym-
phokine production (Fig. 1). These results were consistent with the conclusion that
theseTCRy/S CTL recognized an MHC-linked antigen. However, the BALB/c nu/nu
anti-B10.BR TCRy/S CTL line was broadly crossreactive, recognizing a variety of
allogeneic MHC target cells including H-2k,b.f.9,, (Fig. 2 A). Ofthe panel oftargets
tested, the only allogeneic target cells not lysed expressed the H-2p haplotype.
Two possibilities could explain the high degree ofMHC crossreactivity. First, the
CTL line might havebeen heterogeneous, comprising numerous distinct CTLclones
each crossreactive for a limited subset of allogeneic targets. Alternatively, the in-
dividual TCR-y/8 cells might recognize a relatively nonpolymorphic antigen ex-
pressed on either polymorphic or nonpolymorphic MHC gene products common
to many MHC-disparate strains. To distinguish between thesetwo possibilities, CTL
clones were isolated from the CTL line by limiting dilution andwere examined for
TCR expression and specificity. Two representative clones, F4 and G8, were iso-
lated and shown to be CD3+,CD4-,CD8- based on flow cytofluorometry (FCM)
analysis (data not shown) and TCRy/S expressing as shown by immunoprecipita-
tion (Fig. 3). The G8 (Fig. 2 B) and F4 (data not shown) clones were examined
forcytolysic activity on various allogeneic targets and were found to have the same
reactivity pattern as the parental line. Thus, the high degree of crossreactivity of
the CTL clone indicated that these TCRy/S cells recognized a relatively nonpoly-
morphic antigenic determinant.
To evaluate more precisely the nature of the MHC-linked molecule recognized
by the TCR-y/8 CTL line and clones, CTL specificity was further analyzed by sev-
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FIGURE 2 .
￿
Specificity ofBALB/c CTL line and G8 clone on allogeneic Con A blast target cells .
Distinct target cells are denoted by symbols: open squares, C57BL/10 (bbbbb) ; closed triangles, BIO.M
(fffff); closed circles, B10 .S (sssss) ; open circles, B10.BR (kkkkk) ; closed squares, B10.Q(gqqqq) ; open
triangles, B10T (ppppp); and asterisk, B10.D2 (ddddd). The MHC haplotypes are designated in
parentheses (K-1-D-QTL) .
eral approaches. First, lysis of an H-2k-expressing tumor cell line (R1.1) and its R2-
microglobulin-negative (02M- ) variant (RLE) was examined (Fig . 4 A) . Although
the CTL efficiently lysed the parental class I-expressing cell line, no lysis of the
(32M- mutant was observed . These results suggested that theTCRr/SCTL recog-
nize a 02M-associated antigen, most likely a class I MHC molecule .
FIGURE 3 .
￿
(A) Radiolabeled G8
cells were solubilized and im-
munoprecipitated with the anti-
CD3 mAb and analyzed by
two-dimensional (nonreducing
conditions along the horizontal
axis and reducing conditions
along the vertical axis) off-
diagonal SDS-PAGE gels . Mo-
lecular weights are noted asdots
on the figure . (B) Anti-CD3 and
antiTCRy and antiTCRS im-
munoprecipitates were N-gly-
cosidase-treated or reduced and
alkylated as describedprevious-
ly (5) and run on a one-dimen-
sional gel. Lane 2 represents an
anti-CD3 immunoprecipitated
sample ofG8, while lanes 3 and
4 represent samples reprecipi-
tated with the antiTCRC yl/
Cy2 antiserum (lane 3) or the
antiTCR-Cg antiserum (lane
4) after reduction/alkylation .
Lane 1 represents an anti-CD3
immunoprecipitate followedby
N-glycosidase treatment .1904
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Analysis ofTCR-y/8 cell specificity on H-2- and H-2-congeneic target cells. (A) The
lysis of the TCR-y/8 CTL on R1.1 (open squares) and R1.E (closed squares) cells. (B) The lysis of
targets from H-2q recombinant mice; B10.Q(open circles), B10.AKM (open squares), B10.MBR (closed
triangles), B10.SQR (closed squares), B10.QBR (closed circles), and B10.T(6R) (open triangles).
Next, a more detailed analysis ofthe MHC specificity ofthe CTL line was per-
formed using target cells derived from recombinant, MHC-congenic inbred mice.
Our previous studies localized the target antigen recognized by the TCRy/S CTL
to the D, L, Q, orTL regions ofthe MHC (21). For example, B10.OL (H-2Kd, Dk),
but not B10.A (H-2K', Dd), were lysed by the BALB/c nu/nu anti-B10.BR TCRy/S
CTL line. Similar H-213-end reactivity ofthe CTL was observed on the crossreac-
tive H-26 haplotype(21). Further analyses, performed in the present studies, demon-
strated that the CTL were broadly crossreactive on target cells from recombinant
H-2q strains (Fig. 4 B). Although the CTL line lysed target cells from the B10.Q
strain (H-2Kq, D9), it did not lyse either B10.AKM (H-2Kk, D9) or B10.T(6R)
(H-2Kq, Dd) targets (Fig. 4 B). These results implied that either the CTL recogni-
tion required the expression ofH-29 genes encoded in both the Kand Dend of the
MHC, or that the CTL recognized an MHC-linked molecule other than H-2Kq
or H-2Dq. This latter possibility was supported by further analysis using other H-2q
recombinant strains, namely B10.MBR (H-2Kb, Dq), B10.QBR (H-2K6, Dq), and
B10.SQR (H-2K3, Dq) (Fig. 4 B; reference 33). The CTL lysed the B10.QBR but
not B10.SQR or B10.MBR target cells. Although all ofthe strains are H-213q, the
TL genes ofthese mice are ofdifferent origins (33). Specifically, whereas the B10.Q
and B10.QBR haplotypes express TLaa (derived from the DBA/1 strain), the
B10.AKM, B10.SQR, and B10.MBR express TLac (derived from an outbred
mouse). Thusthe dataindicate that theseCTLmay recognize an MHC class I mol-
ecule encoded in the TL region ofthe TLaa phenotype. This conclusion was sup-
ported by the finding that several anti-H-213 and Qregion-specific mAbs did not
inhibit CTL activity (data not shown). In addition, B10.M (H-2r) cells are lysed by
theCTL. This result wasofinterest in view ofrecent studiesby Flaherty et al. (33a),
who have shown that in the H-2rhaplotype (B10.M strain) the QI through Q9 genes
have been deleted, including Q7, which is thought to encode the Qa-2 gene product.
Thus, it would appear that the BALB/c nu/nu anti-B10.BR CTL linedoes notrecog-
nize a Qregion-encoded gene product. Finally, an H-2d haplotype pre-B cell lineBLUESTONE ET AL .
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(R8.15) transfected with the H-2D' gene was not lysed by the H-2'-specific BALB/c
CTL (data not shown) .
BiochemicalAnalysis ofthe 7L'R Expression on theMHC Antigen-speck TCR-y/3 CTL.
Detailed biochemicaland molecularanalyses of theTCR proteins expressedby these
class IMHC antigen-specific TCR-y/8 cells were performed in order to determine
similarities or differences between these TCRy/S cells andthe predominant TCRy/S
populations described in the thymus and peripheral lymphoid organs . Initial bio-
chemical analysis of the G8 cells suggested that the same predominant disulfide-
linkedTCRproteins were expressed on theclonesand parental CTL line ason bulk
TCRy/S thymocytes (3, 7) (Fig . 3 A) . To determinewhich molecular weight species
represented the individual TCRy andTCRS proteins expressed on the G8 clone,
the TCR proteins were immunoprecipitated with specific antiTCR antisera after
dissociating the chains by reduction and alkylation . As shown in Fig. 3 B, the anti-
TCRCyl/Cy2 antiserum specifically reacted with the lowM r protein (35 x 103 ; lane
2 vs. 3), while the antiTCRS antiserum preferentially reacted with the high M,
protein (45 x 103) (lane 2 vs . 4) of the 80 x 103Mr heterodimer . The degree of
N-linked glycosylation of the 35 x 103 M, TCRy protein was next examined by
treating immunoprecipitated samples with N-glycosidase. Analogous to previous
findings in the BALB/c and B6 strains of mice (3, 7), the TCRy protein immuno-
precipitated by the anti-CD3 antibody wasN-glycosylated (lane 1 vs. 2) . N-glycosidase
treatment reduced theMr of theTCRS chain from 45 to 37 x 10 3 and the TCR-y
chain from 35 to 32 x 103 M, . Therefore, this heterodimer apparently represents
the previously described TCRVy2Cy1/S/CD3 complex that is expressed on the
majority o£ CD3+,CD4-,CD8 - BALB/c fetal and adult thymocytes (3, 7) .
Molecular Analysis of the 7LR Proteins Expressed on theMHC Antigen-speck TCR-y/3
CTL. Although initial N-linked glycosylation analysis suggested that the TCRy
protein expressed on the BALB/c alloreactive TCRy/S cells was derived froma rear-
ranged V y-Cyl, the precise V y gene expressed could not be assigned because V y2,
Vy3, and V y4 have all been shown to rearrange to the Cy1 gene (10) . To address this
question, molecular analyses ofTCR-y genes expressed in the alloreactive TCRy/S
CTLwere performed . Previously published Southern blot analysis ofEcoRI-digested
genomic DNA (10) have shown two predominant TCRy rearrangements using a
y constant region probe specific for Cyl/Cy2/Cy3 . A 16-kb rearranged fragment
results from joining of the V10 .8A (Vy 1.2) segment to theJ y2 segment, encoding
a Vy1.2-C10.5 (C),2) protein, while a 17kb band represents a V y2 gene rearrange-
ment (Vy2-C13.4 (Cyl)) (10) . Fig . 5 illustrates a Southern blot analysis of Eco
RI-digested genomic DNA from BALB/c liver and the alloreactive TCR-'Y/8 CTL
using V yDNA probes . Upon Eco RI digestion of germline BALB/c liver DNA, two
restriction fragments of 5.7 kb and 10.8 kb hybridize to the Vyl probe, a 5.2-kb frag-
ment hybridizes to the V y2 probe, and 7-kb bands hybridize to the Vy3 and V y4
probes (Fig. 5) . Both the Vy3 and V y4 genes remain in the germline configuration
in the BALB/c TCRy/S line and the F4 clone . In contrast, both the Vyl and V y2
genes have rearranged in the CTL line and clones .
In addition, both Vyl and V y2 were expressed as full-length TCRy mRNAs in
the BALB/c nu/nu line and theG8 line (Fig. 6) . However, V y2-Cy1 but not Vyl.2-Cy2
encodesa glycosylated protein(34) . Thus, from the combined biochemical andmo-1906
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FIGURE 5 .
￿
Southern Blot analysis of TCR-y rear-
rangements in the TCR-y/8 BALB/c nu/nu anti-
B10.BR alloreactiveT cell line and the F4 clone . Eco
RI-digested DNA from liver (germline) and theT
cell line and clone were hybridized to each ofthe four
probes shown . Performance of the Southern anal-
ysis and the origin of the probes are described in
MaterialsandMethods . The sizes ofthe hybridizing
bands are shown (kb) .
lecular biologic analyses, it can be concluded that the alloreactive BALB/c nu/nu line
and clones express the TCR-y protein product of a V y2-Cyl gene .
Analysis of7UR-6 Gene Expression .
￿
TCR8mRNA expression in the MHC-specific
line was confirmed using a C8 probe (Fig. 6) . MessengerRNA species of 2.0 and
1 .6 kb were obeserved in the BALB/c nu/nu anti-B10.BR TCRy/S cells, consistent
with previous reports (17) . Moreover, truncatedbut not full-lengthTCRa andTCR0
mRNAs were expressed (Fig. 6), which confirmed the exclusive expression ofTCR-
y/S in these cells. In contrast, no TCRS mRNA could be detected in a TCR-a/R
expressing spleen cell population .
TCR-S rearrangements in the alloreactive line and the G8 clone were next exam-
ined with twoJs probes (19) capable of detecting rearrangements to either of the
twoJ$ gene segments,Js1 orj,52, that have been identified (Fig. 7) . Two predomi-
nant rearranged bands of6.2 and 4.8 kb were observed after hybridization of Eco
RI-digestedDNA from the BALB/c line and G8 clone to the 3''5l probe . For com-
parison, TCR-8 rearrangements were also examined in bulk TCR-y/8 spleen cells,
a BALB/c spleen-derived CD3+,CD4-,CD8- T cell population propagated in vitroBLUESTONE ET AL .
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FIGURE 6.
￿
Analysis ofTCRgene expres-
sion in TCR-y/S alloreactiveT cells . RNA
was prepared from the T cell population
shown and was examined for the expres-
sion of the indicated TCR genes . The
origin ofthe probes and the performance
of the Northern analysis is described in
Materials andMethods . The sizes of the
RNA species were determined by using 5.1
kb and 2.0 kb for ribosomal 28S and 18S
as markers . Equalloading oftheRNAper
lane wasdetermined by ethidium staining
ofthe gels. LaneA representsRNAfrom
acytochrome c-specific TCR-a/9Th cell,
FLA2 . Lane D represents RNA from
wholeB10 spleen cells cultured with anti-
CD3 as described in Materialsand Meth-
ods. Lanes Band ErepresentRNAfrom
the BALB/c nu/nu anti-B10.BR TCRy/S
CTL line, while lanes C andFrepresent
RNA from the TCR-y/8 clones F4 and
U8, respectively.
for 1 wk by nonspecific stimulation with the anti-CD3 mAb 145-2011, as described
in the experimental procedures section (5). At least fourj,51 rearranged bands, in-
cluding apredominant one of 7.4 kb, were observed in the bulk TCR'Y/8 cells . The
6.2-kbrearrangement ofthe alloreactive CTL but notthe 4.8-kb rearrangement was
also detected in the unselected TCR-y/8T cells . Analysis of theJa2 locus failed to
detect any rearrangements in either the alloreactive CTL or the bulk TCRy/8 T
cells, consistent with the prior observation (19) that rearrangements to theJa2 seg-
ment are far less frequent than to j,51 .
To characterize the 7L'R-6 gene, acDNA library was constructed in phage %gt10
from the BALB/c nu/nu anti-1310.131kT cell line, and TCR-S cDNA clones were iso-1908
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FIGURE 7 .
￿
Southern Blot analysis of TCR-6 rearrangements in the
BALB/c anti-B10.BR alloreactive TCR-,y/8 line. DNA from BALB/c
liver, theBALB/c nu/nu anti-B10.BR TCR-y/8-expressing T cell line,
theG8 clone, and a CD3',CD4-, CD8- BALB/c splenicT cell pop-
ulation propagated in vitro for 1 wk by stimulation with the anti-CD3
mAbwas digested with EcoRI (top) or HINDIII (bottom) and hybrid-
ized to the 3J61 andJ82 probes, respectively. Southern analysis was
performed as described in Materials and Methods . The sizes of the
hybridizing bands are shown (kb) .
lated using the CS probe . Eco RI digestion of purified phage DNA from colonies
containing putative TCR-8 inserts produced several recombinants consisting of a
0.9-kb fragment (the size of thecDNA fragment encoded by the CS gene downstream
of its internal Eco RI site and 3' untranslated sequence) (17) as well as one or more
additional smaller fragments . Several of the fragments, most likely to contain both
C6 and variable gene elements, were subcloned and sequenced . The sequence of
a representative 369-bp fragment, 6G8, is shown in Fig. 8. The clone encodes 5'
CS sequence virtually identical to that previously published (17), followed upstream
byJS1, DS2, and DSl . Assignments ofj81, DSl, andDS2 are based upon the pub-
lished germline sequences (19, 20) . N region nucleotides are present between D62
andJSl, and between the V segment and DSl . The inclusion of both D81 and DS2
gene segments is analagous to that observed in previously described TCR-8 cDNA
clones derived from adult butnot fetal thymocytepopulations (19, 20) . The putative
V6 gene segment was distinct from any previously published unique VS sequences
derived from fetal or adult thymocytes cDNA clones (17, 19, 20), but was found to
be >95% homologous at theDNA level to a previously reported Va gene segment
designated Vall.l (35) . The identity of V6G8 with the Va gene family was also sup-
ported by the fact that the 5' end of the subcloned 6 fragment represented the exactQ
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site of an internal Eco RI site within the published hall.l sequence (35) . Moreover,
a Vall.l Vsegment probe derived from an antigen-specificTCRa/R-expressing T
cell clone (28) hybridized to a 2.0-kb mRNA in both the BALB/c nu/nu line and
the G8 clone (Fig. 6) and to theJ81-hybridizing 4.8-kb rearranged band (Fig . 7) .
Generation of a Distinct MHC-speck TCR-ylS-expressing CTL Line .
￿
The apparent
TL-linked specificity and high degree of cross-reactivity of the BALB/c nu/nu anti-
Bl0.BR TCRy/8 cell line appeared to contrast with the majority ofTCR-a/R-express-
ing CTL previously described (36) . In order to further explore the repertoire of
TCR-y/6-bearingTcells, studieswere undertaken to generate additional MHC-spe-
cific TCR-y/8 cells . Lymph node cells from C57BL/10 (1310) nulnu mice, primed in
vivo with allogeneic B10.BR spleen cells, were restimulated in vitro as previously
described (21) . After 7 wk ofculture the resulting cell line was analyzed for cell sur-
face phenotype, antigen specificity andTCR expression . First, the B10 nu/nu anti-
B10.BR line was shown to be CD3~,CD4-,CD8 - (data not shown) and cytolytic.
The antigen specificity was therefore examined in cytolytic assays . As was previ-
ously observed for the BALB/c TCR-y/8 CTL line, the B10 nu/nu CTL line was
specific for an antigen localized to the D, L, Qa, or TLa regions of the MHC (Fig.
9) . For example, the H-2'-specificCTL lysed B10.BR (H-2Kk, Dk) andC3H.KBR
(H-2K', Dk), but not 1310 (H-2Kb , Db) or B10.A(4R) (H-2Kk,Db) target cells . How-
ever, in contrast to the BALB/c nu/nu TCRy/8 CTLline, the antigenic determinant
recognized by the B10 nu/nu TCR- ,y/8 CTL was not expressed on allogeneic target
cells and did not map to the H-2TL gene loci . The CTL lysed C3H.KBR (H-
2Kb,Dk,Qk,TLk) but not B6.K1 (H-2Kb,Db,Q`,TLk). Therefore, the lytic activity of
this CTL line maps to the H-2D' locus, a specificity classically observed for TCR-
a/(3 CTL.
TheTCR complex expressed on this line was examined by two-dimensional non-
reduced/reduced SDS-PAGE of radiolabeled immunoprecipitates (Fig . 10) . Anti-
CD3mAb(top paneo immunoprecipitated adisulfide-linked TCR dimer(nonreduced
mol wt 90 x 103 , reduced mol wt 45-47 x 103) distinct from the TCRy/8 proteins
expressed by the BALB/c TCR-y/8 CTL line and distinct from TCR-a/0 proteins
expressed by B10 spleen cells (data not shown) . We have recently identified T cells
FIGURE 9 .
￿
Lysis of target blast cells
from MHC congeneic mice by the
C57BL/10 nu/nu anti-B10.BRCTL . (a)
TheMHC haplotypes (K-I-D-QTL)
are : B10.BR (kkkkk), C3H.KBR
(bbkkk), B10 (bbbbb), B10.A(4R)
(kkbbb), B6.K1 (bbbkk), andBMW
(ddddd) .BLUESTONE ET AL .
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FIGURE 10.
￿
Detailed characterization oftheTCR
y/S protein expressed on the B10 nu/nu anti-B10.BR
CTL . Anti-CD3 mAb (top) and antiTCRCy4
antiserum (bottom) was used to immunoprecipi-
tate radiolabeledCTL . The immunoprecipitates
were analyzed by two-dimensional (nonreducing
conditions along the horizontal dimension and
reducing conditions along the verticaldimension)
offdiagonal PAGE gels . Molecular weights are
noted as dots on the figure.
in the periphery of normal B10 mice that express a TCR complex consisting of a
TCRS chain disulfide-linked to the product of the 7L'R-Cy4 gene (5) . Our studies
usingan antiserum developed against a peptidecorresponding to the COOH-terminal
region of the predicted Cy4 gene product (37) precipitated at least two heterodi-
meric structures, one of which migrated at a molecular weight similar to the B10
anti-B10.BR line. Therefore, lysate of radiolabeled B10 anti-B10.BR CTL was im-
munoprecipitated with the anti-Cy4 antiserum. As seen in the lower panel (Fig . 10),
the antiserum immunoprecipitated the same TCR proteins as the anti-CD3 anti-
body (upper paneo, consistent with the conclusion that this cell line expresses a
TCR-y/8 heterodimer and that theTCRy chain is encoded by a rearranged Vy/Cy4
gene .
Discussion
The identification ofT cells that express TCRy/S proteins has led to an active
interest in determining the specificity, repertoire, and physiologic function of this
novelTcell subset . Initial studies demonstrated that TCRy/S T cells, isolated from
peripheral T cell populations and activated with an array of antigen-independent
stimuli such as mitogens or mAbs, develop non-MHC-restricted cytolytic activity
(38, 39) . For instance, CD4-,CD8- humanT cell clones activated with Con A, IL-
2, and allogeneic spleen cells lyse a variety oftumor targets including NK-sensitive
targets (38) . Thus, it has been suggested that the lymphokine-activated killer ac-
tivity reported in activated peripheral lymphocytes may, in part, be mediated by
T cells expressing the TCRy/S receptor (40) . It has also been suggested that TCR-
y/ST cells recognize tumorantigens and function in vivo in tumor surveillance (39)1912
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byrecognizing non-MHC-restricted tumortarget antigens. In fact, in some instances,
the non-MHC-restricted lytic activity was inhibited by anti-CD3 or antiTCR anti-
bodies (38, 40). However, recent studies inourlaboratory and others (41)have raised
questions as to the role ofthe TCRy/S receptor in mediating this activity. There-
fore, our efforts have focused on generating antigen-specific TCR-y/8 cells.
As an approach to identifying the ligand(s) and exploring the repertoire for T
cells expressing TCRy/8, we have established alloreactive T cell lines and clones
from the peripheral lymph nodes of athymic nu/nu mice stimulated with allogeneic
spleen cells. Two independent T cell lines have been described in this report. Both
CTLlines have the CD3+,CD4-,CD8- phenotype, express a TCRy/8 receptor, and
recognize an MHC-linked class I antigen. However, the specificity and the receptor
usageofthetwo CTL populationsare distinct. One CTLline, andthe clones derived
from that line, expressed a TCR complex composed ofthe product ofa rearranged
Vy2/Cyl gene associated with a TCR8 protein encoded by awell-characterized Va
gene segment, Vall, rearranged to both the Das and theJ61 variable gene elements.
Functional analysisofthe BALB/c nu/nu T cellline showed that it recognized a rela-
tively nonpolymorphic MHC-linked class I molecule mapping within orto theright
oftheTL region ofthe MHC complex. Basedontheseinitial results, itisinteresting
to speculate that the TCRy/8 cells have evolved to recognize a distinct subset of
MHC antigens encoded by the H-2Qand H-2TL regions. In fact, the abundance
of TCRy/8 cells in the epithelia of the skin may provide a unique role for these
cells in the recognition ofcertain infectious agents presented in the context of non-
MHC K, D, or L geneproductsormodifiedclass I antigens. The TLor Qregion-en-
coded class I antigens may be preferentially expressed on peripheral APC located
in epithelia enriched for TCRy/8 cells. Alternatively, the presence ofboth TL an-
tigens and TCRy/8-expressing T cellsearly in thymus ontogeny may suggest arole
for these antigens in thymic education ofTCRy/8 or TCRa/R cells. The fact that
the MHC antigens that may be recognized (TLa or Qa) are less polymorphic may
also explain the apparently limited Vy and Va gene usage observed in the whole
TCRy/8 population (10; Fig. 6). However, the demonstration ofclassical H-2Dk-
specific class I MHC alloreactivity in the second y/8 receptor expressing T cell line
we have described suggests a potentially more diverse repertoire.
Sequence data available from the limited number of MR-6 genes studied to date
has revealed several that use known Va segments rearranged to Da andJa elements,
although the majority appear to express a unique subset of Va genes (19, 20). The
expression ofa Va gene segment by our MHC-specific y/8 receptor-bearingT cells
may have implications for the repertoire of these cells. Although the TG'R-y locus
has limited germline diversity, the potential for extensive diversity of TCR8 has
already been suggested by the observation that the majority offull-length 8 cDNAs
derived from an adult thymocyte cDNA library encode sequences from both Dal
and Da2 gene segments, allowing for the addition of N region nucleotides at the
three distinct junctions (V-1381, Dsl-1382, and D82Js). The expression of Va genes
iny/8 receptors could further amplify their potential diversity. In fact, ifadditional
analysis indicates that the entire germline Va repertoire can participate in the for-
mulation of functional TCR-8 genes, then the potential diversity of the TCR-y/8
maybe much greater than originally proposed basedupon the limitedTCR-y germ-
line repertoire and the apparent limited diversity ofthe expressed y/8 receptors ob-
served in unselected thymocyte and peripheral CD3+,CD4-,CD8- T cell popula-tions (10) . These observations may be particularly pertinent in lightof recent studies
with TCRR transgenic mice (42) . These mice express only the TCRR protein en-
coded by the transgene (endogenous 7CR-,O genes are incompletely rearranged) in
association with a heterogeneous host-encoded TCR-a repertoire, and are neverthe-
less reported to manifest normal allogeneic responses . The TCR-y/S repertoire has
the potential to be at least as diverse as the TCR-a/(3 repertoire of such transgenic
animals . Moreover, the expression ofa Va gene in the first MHC antigen-specific
TCR- ,y/8-bearingT cell invites speculation that this association may not be fortui-
tous. One striking difference between most V a genes and the unique Va gene seg-
ments thus far isolated appears to be that unlike most Va genes, Va genes represent
single copy families (20) . Perhaps TCRy/S that express the unique Vs segments
recognize a distinct set of antigens and thoseTCR expressing V a gene elements will
comprise the majority of TCRy/S cells with MHC-linked specificity.
Interestingly, the Va11 gene segment of8G8 has been previously shown to be the
predominant TCR-a gene expressed in a class II MHC-restricted antigen response
(28, 35, 43) . Thus, it is possible that TCRy/S receptors have the potential to recog-
nize a broad range of MHC-encoded ligands . We have shown here that whereas
the BALB/c anti-B10.BRT cell clones appear to recognize a nonconventional class
I MHC antigen encoded within the TL region, the B10 nu/nu anti-BlO.BR y/S T
cell line recognizes a conventional class I MHC molecule encoded within the
H-2D' subregion . It may be that additional TCR-y/S T cells will recognize class
IIMHC molecules as well as avarietyofnon-MHC peptides in an MHC-restricted
fashion, analogous to TCRa/o . Analysis of additional MHC-specific TCR-y/S-
expressing T cell lines and clones is in progress to address these questions .
Summary
Analyses ofTCRbearing murine andhumanT cells have defined a unique sub-
population ofT cells that express the TCR-,y/6 proteins . The specificity ofTCR-Y/8
T cells and their role in the immune response have not yet been elucidated . Here
we examine alloreactive TCR-y/S T cell lines and clones that recognize MHC-
encoded antigens . ABALB/c nu/nu (H-2d)-derived H-2k specific T cell line and de-
rived clones were both cytolytic and released lymphokines afterrecognition of a non-
classical H-2 antigen encoded in theTL region of theMHC. These cells expressed
the Vy2/Cyl protein in association with a TCRS gene product encoded by a Va
gene segment rearranged totwo Ds and oneJ8 variable elements . A second MHC-
specific 1110 nu/nu (H-2b) TCR-y/8 T cell line appeared to recognize a classical
H-213-encodedMHC molecule and expressed a distinct Vy/Cy4-encoded protein .
These data suggest that many TCR-'Y/S-expressing T cells may recognize MHC-
linked antigens encodedwithin distinct subregions of theMHC. The role ofMHC-
specific TCRy/S cells in immune responses and their immunological significance
are discussed .
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